論文・総説 - 安齋　達彦

分割表示  77 件中 61 - 77 件目  ／  全件表示 >>

  1. Tatsuhiko Anzai, Keisuke Fukui, Tsubasa Ito, Yuri Ito, Kunihiko Takahashi. Excess mortality from suicide during the early COVID-19 pandemic period in Japan: a time-series modeling before the pandemic. J Epidemiol. 2021.02; 31 (2): 152-156. ( PubMed, DOI )

  2. Yoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, Yuko Kaneko, Eiichi Tanaka, Shinsuke Yasuda, Naoto Tamura, Keishi Fujio, Takao Fujii, Toshihisa Kojima, Tatsuhiko Anzai, Chikuma Hamada, Yoshihisa Fujino, Shinya Matsuda, Hitoshi Kohsaka. Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study. Mod Rheumatol. 2021.01; 31 (1): 42-52. ( PubMed, DOI )

  3. Tomohiro Ishimaru, Yoshihisa Fujino, Tatsuhiko Anzai, Shinya Matsuda, Yoshiya Tanaka. Validity and responsiveness of the Work Functioning Impairment Scale (WFun) in rheumatoid arthritis patients: A multicenter prospective study. Mod Rheumatol. 2020.09; 30 (5): 821-827. ( PubMed, DOI )

  4. Tatsuhiko Anzai, Kunihiko Takahashi, Michiko Watanabe, Mayumi Mochizuki, Atsuko Murashima. Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis. BMC Psychiatry. 2020.03; 20 (1): 118. ( PubMed, DOI )

  5. Yoshiya Tanaka, Hideto Kameda, Saito Kazuyoshi, Yuko Kaneko, Eiichi Tanaka, Shinsuke Yasuda, Naoto Tamura, Keishi Fujio, Takao Fujii, Toshihisa Kojima, Tatsuhiko Anzai, Yoshihisa Fujino, Shinya Matsuda, Hitoshi Kohsaka. FACTORS THAT AFFECT THE RESPONSE TO TOCILIZUMAB WITH REGARD TO WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A 2-YEAR FOLLOW-UP OF THE FIRST ACT-SC STUDY Annals of Rheumatic Diseases. 2019.06; 78 ( DOI )

  6. Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Yasuhiro Gon, Shuhei Nakamura, Tatsuhiko Anzai, Kazuto Hirata, Masakazu Ichinose. Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO study Int J Chron Obstruct Pulmon Dis. 2019; 14 1789-1801. ( PubMed, DOI )

  7. Tatsuhiko Anzai, Kunihiko Takahashi, Michiko Watanabe. Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database. Psychiatry Clin. Neurosci.. 2019; 73 (1): 27-33. ( PubMed, DOI )

  8. Yoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, Yuko Kaneko, Eiichi Tanaka, Shinsuke Yasuda, Naoto Tamura, Keishi Fujio, Takao Fujii, Toshihisa Kojima, Tatsuhiko Anzai, Chikuma Hamada, Yoshihisa Fujino, Shinya Matsuda, Hitoshi Kohsaka. Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study. Arthritis Res. Ther.. 2018; 20 (1): 151. ( PubMed, DOI )

  9. Masakazu Ichinose, Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Yasuhiro Gon, Tetsuo Seki, Tatsuhiko Anzai, Shuhei Nakamura, Kazuto Hirata. Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity. Int J Chron Obstruct Pulmon Dis. 2018; 13 1407-1419. ( PubMed, DOI )

  10. Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Yasuhiro Gon, Tetsuo Seki, Tatsuhiko Anzai, Shuhei Nakamura, Kazuto Hirata, Masakazu Ichinose. Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study European Respiratory Journal. 2018; 52 ( DOI )

  11. Masakazu Ichinose, Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Tetsuo Seki, Tatsuhiko Anzai, Ayako Takizawa, Lars Grönke, Kazuto Hirata. Study design of VESUTO; efficacy of tiotropium/olodaterol on lung hyperinflation, exercise capacity, and physical activity in Japanese patients with COPD Adv Ther. 2017; 34 (7): 1622-1635. ( PubMed, DOI )

  12. Kaori Nomura, Kunihiko Takahashi, Yasushi Hinomura, Genta Kawaguchi, Yasuyuki Matsushita, Hiroko Marui, Tatsuhiko Anzai, Masayuki Hashiguchi, Mayumi Mochizuki. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases. Drug Des Devel Ther. 2015; 9 3031-3041. ( PubMed, DOI )

  13. Anzai T, Shimadzu H, Endo T. Modelling duration of necessary and non-necessary activities in daily life: fitting mixture models to Japanese time use survey data. Proceedings of the 23rd International Workshop on Statistical Modelling (Ed. P. Eilers). 2008; 93-98.

  14. 長谷川嵩矩, 安齋達彦, 高橋邦彦. AI・機械学習とデータサイエンス 体育の科学. 2021.11; 71 (11): 764-768.

  15. 遅野井 健, 志岐 甲介, 石田 真大, 唯保 祐介, 安齋 達彦, 宮本 悠希, 生島 一平. 日本人健康成人男性を対象としたエンパグリフロジン・リナグリプチン配合錠のバイオアベイラビリティに対する食事の影響　ランダム化、単回投与、2群クロスオーバー試験 薬理と治療. 2018; 46 (3): 343-353. ( 医中誌 )

  16. 降旗 謙一, 中道 昇, 関 哲郎, 唯保 祐介, 安齋 達彦, 黒木 大介, 西村 誠一郎, 檜垣 實男. 日本人健康成人男性を対象としたテルミサルタン80mg/アムロジピン5mg/ヒドロクロロチアジド12.5mg配合剤の生物学的同等性試験および食事の影響試験 薬理と治療. 2016; 44 (5): 689-702. ( 医中誌 )

  17. 野田 寿恵, 安齋 達彦, 杉山 直也, 平田 豊明, 伊藤 弘人. 精神保健福祉資料(630調査)を用いた隔離・身体拘束施行者数の分析 精神医学. 2012; 54 (3): 317-323. ( DOI 医中誌 )

< 前のページ - 次のページ >

このページの先頭へ▲